Aptevo Therapeutics Inc. (APVO) Social Stream
APTEVO THERAPEUTICS INC (APVO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering APTEVO THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 2 | $69 | $50 | $59.5 | $0.177 | 33515.82% |
| 2022-05-12 | 2 | $69 | $36 | $52.5 | $0.177 | 29561.02% |
| 2022-05-13 | 2 | $36 | $20 | $28 | $0.177 | 15719.21% |
| 2023-02-13 | 1 | $23 | $13 | $18 | $0.177 | 10069.49% |
| 2023-02-21 | 2 | $23 | $13 | $18 | $0.177 | 10069.49% |
| 2023-04-24 | 2 | $18 | $13 | $15.5 | $0.177 | 8657.06% |
| 2023-07-19 | 2 | $18 | $11 | $14.5 | $0.177 | 8092.09% |
| 2023-08-10 | 1 | $12 | $12 | $12 | $0.177 | 6679.66% |
| 2023-11-14 | 1 | $10 | $10 | $10 | $0.177 | 5549.72% |
The Trend in the Analyst Price Target
APVO's average price target has moved down $20.5 over the prior 43 months.
APVO reports an average of 1,606.68% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-13 | 2 | 23 | 13 | 18.0 | 2.030 | 786.7% |
| 2023-04-28 | 2 | 18 | 11 | 14.5 | 1.920 | 655.21% |
| 2023-07-19 | 2 | 18 | 18 | 18.0 | 0.884 | 1936.2% |
| 2023-07-19 | 2 | 18 | 11 | 14.5 | 0.884 | 1540.27% |
| 2023-07-19 | 1 | 18 | 11 | 14.5 | 0.884 | 1540.27% |
APVO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
APVO's average broker recommendation rating improved by 0 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- APTEVO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 998.75% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, APTEVO THERAPEUTICS INC's number of analysts covering the stock is greater than 16.98% of them.
- In terms of how APTEVO THERAPEUTICS INC fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -370.24% of that group.
- APVO has a higher average analyst price target than 726.88% of stocks in the micro market cap category.
Stocks similar to APTEVO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PPBT, QLGN, and VTVT.
View All Top Stocks by Price Target
Is APVO a Buy, Hold or Sell? See the POWR Ratings now!